U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
139261139261Screening for Primary Ciliary Dyskinesia Using Nasal Nitric OxideNot yet recruitingNo Results AvailablePrimary Ciliary Dyskinesiahttps://ClinicalTrials.gov/show/NCT00739817
139262139262Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate CancerCompletedNo Results AvailableProstate CancerBehavioral: exercise intervention|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: proteomic profiling|Genetic: reverse transcriptase-polymerase chain reaction|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Procedure: psychosocial assessment and care|Procedure: quality-of-life assessment|Procedure: support group therapy|Procedure: therapeutic dietary interventionhttps://ClinicalTrials.gov/show/NCT00739791
139263139263Effect of a Novel Sweetener on the pH of Dental Plaque.CompletedNo Results AvailableDental CariesOther: food - novel sweetener|Other: food vehicle blank|Other: food - sweetener, positive control|Other: food - sweetener, negative controlhttps://ClinicalTrials.gov/show/NCT00739778
139264139264Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress DisorderCompletedNo Results AvailablePost-Traumatic Stress DisorderBehavioral: Interpersonal Psychotherapy|Behavioral: Prolonged Exposure Therapy|Behavioral: Relaxation Therapyhttps://ClinicalTrials.gov/show/NCT00739765
139265139265Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) ClinicsCompletedNo Results AvailableHepatitis B VirusBehavioral: Message Framing|Behavioral: Intention|Behavioral: Recommendationhttps://ClinicalTrials.gov/show/NCT00739752
139266139266An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial CystitisCompletedNo Results AvailableInterstitial Cystitis|Painful Bladder SyndromeDrug: PD 0299685 at 15mg BID|Drug: PD 0299685 at 30mg BID|Drug: placebo for PD 0299685https://ClinicalTrials.gov/show/NCT00739739
139267139267Effects of Sea Buckthorn Oil on Dry EyeActive, not recruitingNo Results AvailableDry Eye SyndromesDietary Supplement: Sea buckthorn (Hippophaë rhamnoides) oil|Dietary Supplement: Placebo comparisonhttps://ClinicalTrials.gov/show/NCT00739713
139268139268Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP MonitoringActive, not recruitingNo Results AvailableHemodynamics|Blood Pressure|Physiologic Monitoringhttps://ClinicalTrials.gov/show/NCT00739700
139269139269Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart FailureTerminatedNo Results AvailableChronic Heart FailureDrug: ALT-711|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00739687
139270139270SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)CompletedHas ResultsHypertensionDrug: losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB])|Behavioral: Low Salt Diethttps://ClinicalTrials.gov/show/NCT00739674
139271139271A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete RemissionCompletedHas ResultsOvarian CancerDrug: Vismodegib 150 mg|Drug: Placebo to vismodegibhttps://ClinicalTrials.gov/show/NCT00739661
139272139272A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: MP-376|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00739648
139273139273Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective TinnitusCompletedNo Results AvailableSubjective TinnitusDrug: Neramexane mesylate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00739635
139274139274TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.CompletedNo Results AvailableHIV|AIDS|Oral ContraceptiveDrug: TMC278https://ClinicalTrials.gov/show/NCT00739622
139275139275IDO Inhibitor Study for Relapsed or Refractory Solid TumorsTerminatedNo Results AvailableBreast Cancer|Lung Cancer|Melanoma|Pancreatic Cancer|Solid TumorsDrug: 1-methyl-D-tryptophanhttps://ClinicalTrials.gov/show/NCT00739609
139276139276Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African AmericansCompletedHas ResultsHypertensionDrug: Aliskiren Hydrochlorothiazide (HCTZ): 8 weeks|Drug: Amlodipine: 8 weekshttps://ClinicalTrials.gov/show/NCT00739596
139277139277Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation SolutionsCompletedHas ResultsArthroplasty, Replacement, HipDrug: CHG 2% w/v and IPA 70% v/v|Drug: Iodophor 0.7% and IPA 74% w/whttps://ClinicalTrials.gov/show/NCT00739583
139278139278The Effect of Manipulations of the Lumbar Spine on Six Different Outcome MeasuresCompletedNo Results AvailableLow Back PainDevice: AAI signature IV AMCThttps://ClinicalTrials.gov/show/NCT00739570
139279139279A Pilot Study to Evaluate the Systemic Inflammatory Response of Thoracoabdominal Aortic Aneurysm Repair.TerminatedNo Results AvailableAortic Aneurysm, Thoracic|Systemic Inflammatory Response Syndromehttps://ClinicalTrials.gov/show/NCT00739557
139280139280Chronic Pain After Operation for Breast CancerEnrolling by invitationNo Results AvailablePain ThresholdOther: 1https://ClinicalTrials.gov/show/NCT00739544
139281139281Measuring Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX SystemCompletedNo Results AvailableAsthmaDevice: Exhaled nitric oxide (eNO)https://ClinicalTrials.gov/show/NCT00739531
139282139282Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Neurological ExamsRecruitingNo Results AvailableNervous System DiseasesProcedure: MRIhttps://ClinicalTrials.gov/show/NCT00739518
139283139283Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)CompletedNo Results AvailableHypophosphatasia (HPP)Biological: Asfotase Alfa|Biological: Asfotase Alfahttps://ClinicalTrials.gov/show/NCT00739505
139284139284Testing Strategies for Weight Loss, IICompletedNo Results AvailableObesityBehavioral: financial incentiveshttps://ClinicalTrials.gov/show/NCT00739492
139285139285CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS)CompletedNo Results AvailableMetabolic Syndrome|OverweightDietary Supplement: Weight Losshttps://ClinicalTrials.gov/show/NCT00739479
139286139286Biorest Liposomal Alendronate With Stenting sTudy (BLAST)Active, not recruitingNo Results AvailableCoronary Artery StenosisDrug: Liposomal Alendronate|Drug: Liposomal Alendronate|Drug: Saline infusion (placebo)https://ClinicalTrials.gov/show/NCT00739466
139287139287A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNo Results AvailableAdvanced Solid TumorsDrug: OSI-906|Drug: erlotinibhttps://ClinicalTrials.gov/show/NCT00739453
139288139288Randomized Controlled Trial to Compare Two Anti-scorpion SerumsCompletedNo Results AvailableScorpion StingBiological: serum antiscorpionhttps://ClinicalTrials.gov/show/NCT00739440
139289139289Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid TumorsCompletedNo Results AvailableCancer|Advanced Solid TumorDrug: LBH589https://ClinicalTrials.gov/show/NCT00739414
139290139290Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic AneurysmActive, not recruitingNo Results AvailableAbdominal Aortic AneurysmDevice: Suprarenal Proximal Cuff Extensionhttps://ClinicalTrials.gov/show/NCT00739401

* Görseller ve İçerik tekif hakkına sahip olabilir